Biotechnology
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
Exploring how Kazia Therapeutics’ novel nuclear PD-L1 protein degrader, NDL2, works to overcome immunotherapy resistance in advanced solid tumors.
-
UCSF Scientists Eliminate Deadly Brain Tumors in Mice with B-SYNC Therapy
Engineered B-SYNC CAR-T cells successfully wiped out diffuse midline glioma in mice, paving the way for human clinical trials as early as…
-
Medicare Denies $949 Multi-Cancer Blood Test, Leaving Seniors With Full Bill Until 2029
Despite FDA advisory support, CMS excludes Galleri from coverage, forcing patients to pay out-of-pocket while awaiting a 2029 policy shift.
-
MIT Nanoparticle Vaccine Tuning Strengthens Immune Responses in Mice
MIT researchers use engineered M13 bacteriophage particles to create more effective cancer vaccines, potentially revolutionizing patient outcomes.
-
CAR-T Cell Therapy Explained: How It Works, Approved Blood Cancers, and Key Risks
An oncologist’s viral reel calls it revolutionary; here is the plain guide to the treatment, its FDA-approved uses, response data, and serious…
-
Epitalon Peptide Shows Mixed Results in Lab Studies on Telomeres and Cancer
While a viral reel claims Epitalon reversed aging, lab data shows it extends telomeres in healthy cells but also activates dangerous pathways…
-
BioSapien Begins First-in-Human MediChip Trial for Rectal Cancer at Burjeel
Abu Dhabi startup BioSapien doses first patient in Phase I trial evaluating its biodegradable MediChip implant to deliver localized chemotherapy directly to…
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
Phase 1 data show 87% response and 18-month PFS; pivotal phase 2 met goals but BMS withheld numbers as phase 3 begins.
-
Manufacturing Site Issues Delay FDA Decision on Novo’s Once-Monthly Hemophilia A Drug Denecimig
Bagsværd, October 6 — Novo Nordisk confirmed on October 2 that the FDA review of its denecimig biologics license application remains delayed…
-
FDA Approved All Eight Rare Disease Decisions Due in September 2026, Six of Them Early
WASHINGTON, October 2 — The FDA’s October 2026 decision calendar is relatively light compared to previous months, with a limited number of…
-
Jimmy Carter’s Melanoma Treatment Changed Cancer Care, Doctors Say
Rome, October 1 — The mechanics here are straightforward: immunotherapy, a breakthrough in cancer treatment, has generated significant revenue for biotechnology companies,…
-
Insilico Medicine Launches Longevity Vaccines Research Initiative Targeting Aging Diseases
HONG KONG, September 15 — Insilico Medicine is taking its AI drug-discovery engine into preventive medicine. The Hong Kong-listed company (HKEX: 3696)…
-
Maryland Researchers Find Rattlesnake Blood Proteins About 10 Times More Potent Than Current Antivenom
WASHINGTON, D.C., July 31 — A strategic advance in medical science has emerged from the University of Maryland (UMD), signaling a potential…
-
Review Names dCK Enzyme as Metabolic Target for Cancer Therapy
LOS ANGELES, July 17 — A new comprehensive review is pointing cancer researchers toward an old metabolic enzyme, one that could offer…
-
Next-Generation CAR T-Cell Therapies Aim at Solid Tumors and Off-the-Shelf Donor Cells
SAN FRANCISCO, July 14 — The next generation of cancer immunotherapy is racing toward a milestone that could change how thousands of…
-
Decades of mRNA Research Led to Fastest Vaccines by 2020
ROME, July 10 — The story of messenger RNA vaccines begins not in a pandemic, but in a laboratory mouse. In 1990,…
-
Metformin and Rapamycin: Two Anti-Aging Drug Candidates With Very Different Evidence
NEW YORK, July 8 — The calculus around aging research is shifting. Two drugs, one a decades-old diabetes staple and the other…
-
Pasteur’s 1881 Anthrax Vaccine Trial Was a Public Test, but the Vaccine Was Not What He Claimed
PARIS, July 8 — The mechanics of how a 19th-century chemist reshaped modern medicine are worth dissecting, because the story is less…
-
Pittsburgh Team Finds TPP1 Mutation Helps Melanoma Cells Keep Telomeres Long
PITTSBURGH — Scientists at the University of Pittsburgh School of Medicine have identified a crucial missing piece in the long-standing mystery of…
-
Phage Display, the Virus-Based Method Behind Humira, Earned a 2018 Chemistry Nobel
NEW YORK, July 1 — There is a quiet revolution happening in a corner of biotechnology that most people have never heard…
-
Anixa Biosciences Gets First Korean Patent for Breast Cancer Vaccine
SAN JOSE, June 29 — Anixa Biosciences has secured its first Korean patent for a breast cancer vaccine, a move that extends…
-
Base Editing of Human Embryos Avoids Chromosome Loss but Leaves the Mosaicism Problem
NEW YORK, June 9, 2026 — infopulsetoday.com —The embryos were not perfect. Some cells carried the edit. Others did not. That is…
-
Google Asks EPA for Permit to Release Up to 32 Million Lab-Bred Mosquitoes
SAN FRANCISCO, June 11 — A subsidiary of Google’s parent company has submitted a request to federal regulators for approval to deploy…
-
CRISPR Therapeutics Holds the First Approved CRISPR Therapy, but Its Stock Is Stuck
On December 15, 2023, the biotechnology industry is abuzz with the recent regulatory approval of a groundbreaking treatment by CRISPR Therapeutics AG,…
Most read
-
First Human Data on ER-100: What the Sinclair-Linked Eye Gene Therapy Actually Showed
-
AACR Report Details Rapid Progress in Targeted Cancer Therapies and Survival
-
Study Links High Sugar Intake to 28% Higher Breast Cancer Risk in Korean Women
-
Dexcom CONNECT Study Shows CGM Lowers A1C by 1.6% in Non-Insulin Type 2 Diabetes
-
How Satri-Cel Became the World’s First Approved Solid Tumor CAR-T
-
Missed NHS England cancer‑treatment target threatens bladder‑cancer surgery waiting times
-
AstraZeneca’s Imfinzi Wins FDA Approval for Bladder Cancer Patients
-
How Kazia’s Nuclear PD-L1 Degrader Aims to Overcome Cancer Resistance
-
FDA RMAT and Fast Track Designations Set New Evidence Bar for Cell Therapies
-
How mRNA Technology Is Transforming the Future of Personalized Cancer Vaccines
-
Workers Can Boost Tax Savings by Maximizing New $3,500 Health FSA Limit for 2027
-
Fidelity’s Shift to Managed Accounts and Private Assets: What It Means for 401(k) Savers
-
How Required Minimum Distributions Work and Strategies to Lower Taxes
-
How the 2027 401(k) Limit Increase to $25,500 Changes Retirement Planning
-
BMS GPRC5D CAR-T Arlo-cel Shows Deep Responses After BCMA Failure
-
Understanding the FDA’s Accelerated Approval of Iberdomide for Multiple Myeloma
-
Rockefeller’s 2141-V11 Trial Shows Complete Remission in Two Metastatic Cancer Patients
-
Ellie Sullivan: Genetic Testing Refused for a Decade, Then Offered After Her Diagnosis
-
Personalized mRNA Cancer Vaccine Succeeds in First Phase 3 Melanoma Trial
-
Indiana University Study Ties Delayed Colorectal Cancer Treatment to Higher Metastasis Risk
-
Study: People Who Drank More Water With Meals Ate More Food, Not Less
-
Why Mornings Are Hardest With ADHD: Late Body Clocks, Poor Sleep and Dopamine
-
Immunotherapy and Genome-Based Vaccines Put the Immune System to Work Against Disease
-
Geneticist John Hardy Proposed Alzheimer’s Amyloid Hypothesis in 1992